AngioScore Revenue and Competitors
Estimated Revenue & Valuation
- AngioScore's estimated annual revenue is currently $17.1M per year.
- AngioScore's estimated revenue per employee is $251,000
Employee Data
- AngioScore has 68 Employees.
- AngioScore grew their employee count by -4% last year.
AngioScore Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is AngioScore?
The AngioSculpt Scoring Balloon Catheter significantly alters the landscape for treating both peripheral arterial disease (PAD) and coronary artery disease (CAD). The innovative nitinol scoring element scores the plaque circumferentially, providing a precise and predictable dilatation across a wide range of lesion types. AngioSculpt provides the versatility and effectiveness of a new technology together with the simplicity and deliverability of a high-performance balloon catheter.
keywords:N/A
N/A
Total Funding
68
Number of Employees
$17.1M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AngioScore News
... Market Size, Share, Outlook And Forecast 2022-2030| Key Players Abbott Vascular, Angioscore Ltd., Cordis Corp., Boston Scientific.
... Market Size, Share, Outlook And Forecast 2022-2030| Key Players Abbott Vascular, Angioscore Ltd., Cordis Corp., Boston Scientific.
Other Companies in Fremont
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.5M | 68 | 3% | N/A |
#2 | $8.9M | 68 | 8% | N/A |
#3 | $15M | 68 | 8% | N/A |
#4 | $17.3M | 70 | 17% | N/A |
#5 | $25.2M | 70 | -1% | N/A |